A new treatment for patients with type 2 diabetes could be on the horizon. Researchers recently discovered that Yohimbin, a medication that spent several years in de-registered status, is actually successful at blocking the damaging effects of gene variants that inhibit insulin production. If it becomes a clinical drug, personalized treatment may finally be available for patients who are battling type 2 diabetes.